Teva, Boehringer settle inhaler capsule patent dispute
Adrian Ryan 2019-06-19 2:56 pm By Miklos Bolza | Sydney
Please login to bookmark Close

Israeli drug giant Teva and German drug maker Boehringer Ingelheim have settled their dispute over a patented capsule used to deliver the medicine in Boehringer’s top-selling inhaler Spiriva.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au